Statistically, the existing value difference allows us to admit that the serum value of Lp-PLA2 can be considered a biomarker for the diagnosis of chronic ischaemic heart disease, especially in clinical forms that cannot be certified by the results of other paraclinical examinations performed. Here, PLA2G7 is linked to coronary artery disorder.